A booster vaccination with Spikevax could be given to people over the age of 18 six to eight months after the second dose, the agency said on Monday evening in Amsterdam. In adults, in whom the protection had decreased, the values of the antibodies had increased, according to the experts due to the booster.
The EMA experts had checked data from studies carried out by the manufacturer. According to the recommendation of the EMA, a booster vaccination or a booster contains only half of a normal vaccination dose. The risk of possible side effects is the same as with the second dose of the Moderna preparation.
A decision about a booster vaccination will be made by the national authorities, as the EMA emphasized. The experts had previously enabled the booster vaccination with the preparation from the manufacturers Pfizer and Biontech.